Bridgeway Capital Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $80.2K | Hold |
115,000
| – | – | ﹤0.01% | 1099 |
|
2025
Q1 | $125K | Sell |
115,000
-100,000
| -47% | -$109K | ﹤0.01% | 1001 |
|
2024
Q4 | $215K | Buy |
215,000
+22,200
| +12% | +$22.2K | ﹤0.01% | 987 |
|
2024
Q3 | $318K | Buy |
192,800
+90,000
| +88% | +$149K | 0.01% | 966 |
|
2024
Q2 | $114K | Hold |
102,800
| – | – | ﹤0.01% | 1151 |
|
2024
Q1 | $136K | Sell |
102,800
-10,000
| -9% | -$13.2K | ﹤0.01% | 1173 |
|
2023
Q4 | $169K | Sell |
112,800
-35,000
| -24% | -$52.5K | ﹤0.01% | 1169 |
|
2023
Q3 | $217K | Buy |
147,800
+50,000
| +51% | +$73.5K | 0.01% | 1084 |
|
2023
Q2 | $245K | Sell |
97,800
-53,000
| -35% | -$133K | 0.01% | 1088 |
|
2023
Q1 | $225K | Buy |
150,800
+50,000
| +50% | +$74.5K | 0.01% | 1084 |
|
2022
Q4 | $141K | Buy |
100,800
+10,000
| +11% | +$14K | ﹤0.01% | 1162 |
|
2022
Q3 | $287K | Buy |
90,800
+53,000
| +140% | +$168K | 0.01% | 1056 |
|
2022
Q2 | $131K | Sell |
37,800
-60,000
| -61% | -$208K | ﹤0.01% | 1176 |
|
2022
Q1 | $1.11M | Hold |
97,800
| – | – | 0.02% | 757 |
|
2021
Q4 | $936K | Sell |
97,800
-23,000
| -19% | -$220K | 0.02% | 802 |
|
2021
Q3 | $1.07M | Buy |
+120,800
| New | +$1.07M | 0.02% | 800 |
|
2018
Q3 | – | Sell |
-4,665
| Closed | -$1.28M | – | 1447 |
|
2018
Q2 | $1.28M | Buy |
4,665
+1,250
| +37% | +$342K | 0.01% | 778 |
|
2018
Q1 | $929K | Buy |
3,415
+1,195
| +54% | +$325K | 0.01% | 878 |
|
2017
Q4 | $528K | Sell |
2,220
-2,155
| -49% | -$513K | 0.01% | 1078 |
|
2017
Q3 | $884K | Buy |
4,375
+875
| +25% | +$177K | 0.01% | 885 |
|
2017
Q2 | $406K | Buy |
3,500
+1,250
| +56% | +$145K | ﹤0.01% | 1144 |
|
2017
Q1 | $360K | Hold |
2,250
| – | – | ﹤0.01% | 1159 |
|
2016
Q4 | $392K | Hold |
2,250
| – | – | 0.01% | 1165 |
|
2016
Q3 | $551K | Buy |
+2,250
| New | +$551K | 0.01% | 1050 |
|